OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson’s Disease via the Nrf2/Keap1 Pathway
Qiu-Xu Chen, Ling Zhou, Tao Long, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1014-1014
Open Access | Times Cited: 23

Showing 23 citing articles:

PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 23

A Comprehensive Review on Anti-Inflammatory Response of Flavonoids in Experimentally-Induced Epileptic Seizures
Shyam Sunder Rabidas, Chandra Prakāsh, Jyoti Tyagi, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 102-102
Open Access | Times Cited: 18

Exploring Caenorhabditis elegans as Parkinson’s Disease Model: Neurotoxins and Genetic Implications
Larissa Pereira Dantas da Silva, Érika da Cruz Guedes, Isabel Cristina Oliveira Fernandes, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 6

Focusing on Keap1, IKKβ, and Bcl2 proteins: predicted targets of stigmasterol in neurodegeneration
Manoj Kumar Soni, Awadhesh Kumar, Rakesh Kumar, et al.
Journal of Receptors and Signal Transduction (2025), pp. 1-12
Closed Access

Dexmedetomidine repairs behavioral deficits through miR-365a-3p/G3BP2 axis and Nrf2/Keap1 signaling pathway in traumatic brain injury
Peipei Kang, Yijun Gao, Jie Zheng, et al.
Molecular & Cellular Toxicology (2025)
Closed Access

Identification of Key Active Constituents in Eucommia ulmoides Oliv. Leaves Against Parkinson’s Disease and the Alleviative Effects via 4E-BP1 Up-Regulation
Yuqing Li, Ruidie Shi, Lijie Xia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2762-2762
Open Access

Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models
Rong-Mei Xu, Qiaoju Kang, Xuefei Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3030-3030
Open Access

Artemether exerts neuroprotective effect in Parkinson’s disease through the PI3K/Akt/GSK-3β signaling pathway
Shengli Quan, Jinhua Li, Shuxian Ding, et al.
European Journal of Pharmacology (2025), pp. 177566-177566
Closed Access

Galangin reduces MPTP-induced dopamine neuron injury via the autophagy dependent-PI3K/AKT pathway
Liping Huang, Qiaofeng Li, Jingyi Wu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access

Pharmacological activities and therapeutic potential of galangin, a promising natural flavone, in age-related diseases
Fan Zhang, Yan Yu, Linmei Zhang, et al.
Phytomedicine (2023) Vol. 120, pp. 155061-155061
Closed Access | Times Cited: 12

Analgesic and anti-inflammatory effects of galangin: a potential pathway to inhibit transient receptor potential vanilloid 1 receptor activation
Kaiwen Lin, Datian Fu, Zhongtao Wang, et al.
The Korean journal of pain (2024) Vol. 37, Iss. 2, pp. 151-163
Open Access | Times Cited: 4

Therapeutic potential of flavonoids used in traditional Chinese medicine – a comparative study of galangin, kaempferol, chrysin and fisetin
Arkadiusz Sokal, Klaudia Stocerz, Paweł Olczyk, et al.
Annales Academiae Medicae Silesiensis (2024) Vol. 78, pp. 49-60
Open Access | Times Cited: 3

Neuroprotection of Truncated Peptide IIAVE from Isochrysis zhanjiangensis: Quantum Chemical, Molecular Docking, and Bioactivity Studies
Qiuqi Liu, Liyuan Lin, Huijuan Li, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 692-692
Open Access | Times Cited: 2

Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review
Xiaxia Jin, Wendi Dong, Kaile Chang, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117850-117850
Closed Access | Times Cited: 2

Unveiling the mechanism of platelet dysfunction in Parkinson's disease: The effect of 6-hydroxydopamine on human blood platelets
Samir Kumar Beura, Pooja Yadav, Abhishek Panigrahi, et al.
Parkinsonism & Related Disorders (2023) Vol. 112, pp. 105453-105453
Closed Access | Times Cited: 6

Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease
Feng‐Dan Zhu, Bin‐Ding Wang, Dalian Qin, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 6

Flavonoids Derived from Chinese Medicine: Potential Neuroprotective Agents
J Li, Ye Yu, Y Zhang, et al.
The American Journal of Chinese Medicine (2024), pp. 1-28
Closed Access | Times Cited: 1

Mitigation effect of galangin against aortic dysfunction and hypertrophy in rats with metabolic syndrome
Poungrat Pakdeechote, Anuson Poasakate, Patoomporn Prasatthong, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16500-e16500
Open Access | Times Cited: 3

Cellular stress response and neuroprotection of flavonoids in neurodegenerative diseases: Clinical insights into targeted therapy and molecular signaling pathways
Biswajit Kumar Utpal, Baishakhi Sutradhar, Mehrukh Zehravi, et al.
Brain Research (2024) Vol. 1847, pp. 149310-149310
Closed Access

Page 1

Scroll to top